Upgrade to SI Premium - Free Trial

Cumberland Pharmaceuticals (CPIX)

5.80 -0.04 (0.68%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/11/26)

Latest Headlines

Cumberland reports positive cancer trial results for ifetroban drug June 2, 2026 9:06 AM - StreetInsider Cumberland Pharmaceuticals and Vanderbilt Health Announce Potential New Therapy to Prevent Cancer Metastasis June 2, 2026 9:05 AM - PR NewsWire RedHill explores opaganib for ebola outbreak response June 2, 2026 8:00 AM - StreetInsider RedHill Biopharma Advancing Opaganib Options for Novel Dual Host Directed and Direct Acting Antiviral Approach for Ebola Outbreak Biodefense Platforms June 2, 2026 8:00 AM - PR NewsWire CUMBERLAND PHARMACEUTICALS ANNOUNCES LAUNCH OF VIBATIV® IN CHINA May 28, 2026 9:05 AM - PR NewsWire Form DEFM14A CUMBERLAND PHARMACEUTICA May 26, 2026 6:04 AM - SEC Filing Form PREM14A CUMBERLAND PHARMACEUTICA For: May 15 May 15, 2026 4:33 PM - SEC Filing Form 10-Q CUMBERLAND PHARMACEUTICA For: Mar 31 May 8, 2026 5:02 PM - SEC Filing Cumberland Pharmaceuticals (CPIX) Reports Q1 Loss of $0.13 May 5, 2026 5:29 PM - StreetInsider Form 8-K CUMBERLAND PHARMACEUTICA For: May 05 May 5, 2026 5:07 PM - SEC Filing CUMBERLAND PHARMACEUTICALS REPORTS Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE May 5, 2026 5:00 PM - PR NewsWire RedHill's RHB-204 shows comparable efficacy to RHB-104 in lab tests April 30, 2026 7:03 AM - StreetInsider RedHill's RHB-204 Demonstrates Comparable MAP Killing Efficacy to RHB-104 - Important Step in RHB-204 Development for MAP-related Crohn's Disease April 30, 2026 7:00 AM - PR NewsWire CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE April 28, 2026 4:05 PM - PR NewsWire RedHill Biopharma Announces Full-Year 2025 Financial Results and Operational Highlights April 27, 2026 8:00 AM - PR NewsWire Form 8-K CUMBERLAND PHARMACEUTICA For: Apr 21 April 24, 2026 5:08 PM - SEC Filing Form DEFA14A CUMBERLAND PHARMACEUTICA April 23, 2026 9:03 AM - SEC Filing Cumberland Pharmaceuticals to sell commercial unit to Apotex for $100 million April 23, 2026 9:02 AM - StreetInsider Form 8-K CUMBERLAND PHARMACEUTICA For: Apr 22 April 23, 2026 9:02 AM - SEC Filing Cumberland Pharmaceuticals Announces Strategic Transaction to Integrate Commercial Business with Apotex April 23, 2026 9:02 AM - PR NewsWire RedHill's Opaganib Enhances Efficacy of Neuroblastoma Chemo Combination and Augment Anti-Tumor Immunity in Triple-Negative Breast Cancer in Preclinical Studies - New Data Presented at AACR 2026 April 22, 2026 8:01 AM - PR NewsWire Cumberland Pharmaceuticals gets FDA approval for expanded Caldolor indication April 16, 2026 9:06 AM - StreetInsider CUMBERLAND PHARMACEUTICALS ANNOUNCES EXPANDED INDICATION FOR CALDOLOR® (IBUPROFEN) INJECTION AND LAUNCH OF NEW BRAND WEBSITE April 16, 2026 9:05 AM - PR NewsWire Form 4 CUMBERLAND PHARMACEUTICA For: Mar 18 Filed by: Brown Martin S JR March 20, 2026 5:24 PM - SEC Filing Form 4 CUMBERLAND PHARMACEUTICA For: Mar 18 Filed by: Galante Joseph C March 20, 2026 5:24 PM - SEC Filing Form 4 CUMBERLAND PHARMACEUTICA For: Mar 18 Filed by: Jones James March 20, 2026 5:23 PM - SEC Filing Form 4 CUMBERLAND PHARMACEUTICA For: Mar 18 Filed by: Krogulski Kenneth March 20, 2026 5:22 PM - SEC Filing Form 4 CUMBERLAND PHARMACEUTICA For: Mar 18 Filed by: Young Caroline March 20, 2026 5:22 PM - SEC Filing Form 4 CUMBERLAND PHARMACEUTICA For: Mar 18 Filed by: Anthony Todd M. March 20, 2026 5:21 PM - SEC Filing Form 4 CUMBERLAND PHARMACEUTICA For: Mar 18 Filed by: Bitterman Chris T. March 20, 2026 5:21 PM - SEC Filing Form 4 CUMBERLAND PHARMACEUTICA For: Mar 18 Filed by: Hamm John M. March 20, 2026 5:21 PM - SEC Filing Form 4 CUMBERLAND PHARMACEUTICA For: Mar 18 Filed by: Herman James L March 20, 2026 5:20 PM - SEC Filing Form 4 CUMBERLAND PHARMACEUTICA For: Mar 18 Filed by: KAZIMI A J March 20, 2026 5:20 PM - SEC Filing Form 4 CUMBERLAND PHARMACEUTICA For: Mar 16 Filed by: KAZIMI A J March 18, 2026 5:31 PM - SEC Filing Cumberland Pharmaceuticals Launches New Sancuso® Website Featuring Educational Resources for Chemotherapy-Induced Nausea and Vomiting March 17, 2026 9:05 AM - PR NewsWire Form ARS CUMBERLAND PHARMACEUTICA For: Mar 12 March 12, 2026 5:01 PM - SEC Filing Form DEFA14A CUMBERLAND PHARMACEUTICA March 9, 2026 5:04 PM - SEC Filing Form DEF 14A CUMBERLAND PHARMACEUTICA For: Dec 31 March 9, 2026 5:02 PM - SEC Filing Form 10-K CUMBERLAND PHARMACEUTICA For: Dec 31 March 9, 2026 6:03 AM - SEC Filing Full Article List